AN1 0.00% 0.8¢ anagenics limited

GenomeWeb is very widely read. There is no longer any reason for...

  1. Osi
    16,111 Posts.
    lightbulb Created with Sketch. 201
    GenomeWeb is very widely read. There is no longer any reason for clinicians to say that they hadn't heard or the test, are unsure about it or need more evidence.

    The key strength of the tests (as reported) is the high negative predictive value. Being able to tell many patients that you are 96% or 98 % sure that they don't have bladder cancer (and maybe to take a second test in a few months time to be absolutely sure) MEANS EVERYTHING.

    The stats do the talking!

    cheers
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.8¢
Change
0.000(0.00%)
Mkt cap ! $3.690M
Open High Low Value Volume
0.8¢ 0.8¢ 0.8¢ $336 42K

Buyers (Bids)

No. Vol. Price($)
3 1457234 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 340000 1
View Market Depth
Last trade - 14.19pm 12/07/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.